MediciNova News

MediciNova: Notice regarding the presentation of two topics related to MN-001 (typerkast) at the 92nd European Atherosclerosis Society Annual Meeting (EAS)

May 28 06:00 ET

MediciNova: Notice regarding approval of a patent for MN-166 (ibudilast) targeting the prevention of metastasis of ocular malignant tumors in the United States

May 20 06:00 ET

MediciNova: Internet disclosure matters in connection with the 2024 Annual General Meeting Convocation Notice

May 16 19:00 ET

MediciNova: 2024 Annual General Meeting Convocation Notice

May 16 19:00 ET

MediciNova: Notice regarding approval of a patent applying MN-166 (ibudilast) chlorine gas-induced acute respiratory distress syndrome (ARDS) in the United States

May 14 06:00 ET

MediciNova: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [US GAAP] (consolidated)

May 9 19:00 ET

MediciNova: Supplementary explanation of financial results for the 1st quarter of the fiscal year ending 2024/12

May 9 19:00 ET

MediciNova: Notice regarding patent approval decision for a new sustained release formulation of MN-166 (ibudilast) in the United States

May 7 06:00 ET

MediciNova: Notice of written submission regarding the extension of the deadline for submission of quarterly reports

Apr 19 02:00 ET

MediciNova: Notice regarding the adoption of topics related to the MN-166 (ibudilast) glioblastoma (glioblastoma) clinical trial at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO)

Apr 2 19:00 ET

MediciNova: Notice regarding approval of a new patent targeting macular damage with MN-166 (ibudilast) in Japan

Mar 26 19:00 ET

MediciNova: Notice regarding setting a record date for the Annual General Meeting of Shareholders

Mar 21 02:00 ET

MediciNova: Notice regarding the adoption of two topics related to MN-001 (typerkast) at the 92nd European Atherosclerosis Society Annual Meeting (EAS)

Mar 20 19:00 ET

Medicinova Inc.: Notice regarding presentation of topics related to MN-166 (ibudilast) chlorine gas-induced lung injury at the 63rd Annual Meeting of the Society of Toxicology

Mar 12 06:30 ET

Medicinova, Inc.: Corrected Report (Mass Ownership Report/Change Report)

Feb 27 02:25 ET

Medicinova, Inc.: Change Report

Feb 22 02:19 ET

MediciNova: Supplementary explanation of financial results for the fiscal year ending 2023/12

Feb 20 01:00 ET

MediciNova: Summary of financial results for the fiscal year ending 2023/12 [American GAAP] (consolidated)

Feb 15 18:00 ET

MediciNova: Notice regarding the difference between consolidated earnings and the results for the previous fiscal year

Feb 15 18:00 ET

MediciNova: Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)

Jan 21 19:00 ET